UPMC Hillman Cancer Center, Magee-Womens Hospital is a clinical research site located in Pittsburgh, Pennsylvania, United States 15213.
Crixeo Clinical Trials Trust Score: 95/100 (GOOD). This profile has not yet been claimed by the site owner.
UPMC Hillman Cancer Center, Magee-Womens Hospital has participated in 1 clinical trials.
Therapeutic areas: Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53.
Sponsors: Aprea Therapeutics.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Pennsylvania · View every site in Pittsburgh
Trust Score: 95/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
UPMC Hillman Cancer Center, Magee-Womens Hospital has a Crixeo Trust Score of 95/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UPMC Hillman Cancer Center, Magee-Womens Hospital has 1 clinical trials on record. Their work covers Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53.
UPMC Hillman Cancer Center, Magee-Womens Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.